Cancer Treatment
NOTE: Treatment Options listed are not all-inclusive. Other treatments may be available. ChemoExperts does not recommend any one treatment over another. Only your Doctor can decide this.
- 7 + 3 (Cytarabine + Daunorubicin) for Acute Myeloid Leukemia (AML)
- 7 + 3 (Cytarabine + Daunorubicin) plus Midostaurin (Rydapt®) for Acute Myeloid Leukemia (AML)
- 7 + 3 (Cytarabine + Idarubicin) for Acute Myeloid Leukemia (AML)
- AAVD (Brentuximab vedotin, Doxorubicin, Vinblastine, Dacarbazine) for Hodgkin's Lymphoma (HL)
- ABCP (Atezolizumab (Tecentriq®) + Bevacizumab + Carboplatin + Paclitaxel) for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- Abemaciclib (Verzenio®) for Breast Cancer - metastatic
- Abemaciclib (Verzenio®) + Anastrozole (Arimidex®) for Breast Cancer - early stage
- Abemaciclib (Verzenio®) + Fulvestrant (Faslodex®) for Breast Cancer - metastatic
- Abemaciclib (Verzenio®) + Letrozole (Femara®) for Breast Cancer - early stage
- Abemaciclib (Verzenio®) + Tamoxifen for Breast Cancer - early stage
- Abiraterone (Zytiga®) + Prednisone for Prostate Cancer
- Abraxane® (Paclitaxel protein-bound) for Breast Cancer - metastatic
- Abraxane® (Paclitaxel protein-bound) for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- ABVD (Doxorubicin + Bleomycin + Vinblastine + Dacarbazine) for Hodgkin's Lymphoma (HL)
- AC (Adriamycin® + Cyclophosphamide) followed by THP (Taxol® + Herceptin® + Pertuzumab) for Breast Cancer - early stage
- Acalabrutinib (Calquence®) for Lymphoma, Mantle Cell
- Acalabrutinib (Calquence®) for Chronic Lymphocytic Leukemia (CLL)
- Acalabrutinib (Calquence®) + Bendamustine + Rituximab for Lymphoma, Mantle Cell
- Acalabrutinib (Calquence®) + Obinutuzumab (Gazyva®) for Chronic Lymphocytic Leukemia (CLL)
- Ado-trastuzumab emtansine (Kadcyla®) for Breast Cancer - metastatic
- Ado-trastuzumab emtansine (Kadcyla®) for Breast Cancer - early stage
- Afatinib (Gilotrif®) for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- AIM (Adriamycin® + Ifosfamide + Mesna) for Sarcoma
- Alectinib (Alecensa®) for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- Alpelisib (Piqray®) + Fulvestrant (Faslodex®) for Breast Cancer - metastatic
- Amivantamab (Rybrevant®) for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- Amivantamab (Rybrevant®) + Carboplatin + Pemetrexed for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- Anagrelide (Agrylin®) for Essential Thrombocythemia
- Anastrozole (Arimidex®) for Breast Cancer - metastatic
- Anastrozole (Arimidex®) for Breast Cancer - early stage
- Antithymocyte Globulin (ATG, ATGAM®) + Cyclosporine (Gengraf®, Neoral®) for Severe Aplastic Anemia (SAA)
- Antithymocyte Globulin (ATG, ATGAM®) + Cyclosporine (Gengraf®, Neoral®) + Eltrombopag (Promacta®) for Severe Aplastic Anemia (SAA)
- Apixaban (Eliquis®) for Blood Clots
- Aprepitant (Emend®) for Nausea and Vomiting
- Asciminib (Scemblix®) for Chronic Myeloid Leukemia (CML)
- Atezolizumab (Tecentriq®) for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- Atezolizumab (Tecentriq®) + Bevacizumab for Liver Cancer
- ATRA (Tretinoin) + Arsenic Trioxide (Trisenox®) for Acute Promyelocytic Leukemia (APL)
- ATRA (Tretinoin) + Arsenic Trioxide (Trisenox®) Consolidation for Acute Promyelocytic Leukemia (APL)
- Avapritinib (Ayvakit®) for Advanced Systemic Mastocytosis
- Avatrombopag (Doptelet®) for Immune Thrombocytopenic Purpura (ITP)
- Avelumab (Bavencio®) for Merkel Cell Carcinoma (MCC)
- Avelumab (Bavencio®) for Bladder Cancer
- Axitinib (Inlyta®) for Renal Cell Carcinoma - Kidney Cancer
- Axitinib (Inlyta®) + Pembrolizumab (Keytruda®) for Renal Cell Carcinoma - Kidney Cancer
- Azacitidine (Vidaza®) for Myelodysplastic Syndromes (MDS)
- Azacitidine (Vidaza®) for Acute Myeloid Leukemia (AML)
- BCG (Bacillus Calmette-Guérin, Theracys®, TICE®) for Bladder Cancer
- BCP (Bevacizumab + Carboplatin + Paclitaxel) for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- BEAM (Carmustine + Etoposide + Cytarabine + Melphalan) for Autologous Stem Cell Transplant (autoSCT)
- Belzutifan (Welireg®) for Renal Cell Carcinoma - Kidney Cancer
- Bendamustine + Rituximab for Lymphoma, B-cell
- Bendamustine + Rituximab for Chronic Lymphocytic Leukemia (CLL)
- Bendamustine + Rituximab for Lymphoma, Mantle Cell
- BEP (Bleomycin + Etoposide + Cisplatin) 5-Day for Testicular Cancer
- BEP (Bleomycin + Etoposide + Cisplatin) 3-Day for Testicular Cancer
- Bevacizumab for Brain Cancer
- Bevacizumab (Avastin®) for Ovarian Cancer
- Bevacizumab (Avastin®) + Temozolomide (Temodar®) for Brain Cancer
- Bexarotene (Targretin®) for Lymphoma, T-Cell
- Bicalutamide (Casodex®) for Prostate Cancer
- Bisacodyl (Dulcolax®) for Constipation
- Blinatumomab (Blincyto®) for Acute Lymphoid Leukemia (ALL)
- Bosutinib (Bosulif®) for Chronic Myeloid Leukemia (CML)
- Brentuximab Vedotin (Adcetris®) for Hodgkin's Lymphoma (HL)
- Brentuximab Vedotin (Adcetris®) for Lymphoma, T-Cell
- Brigatinib (Alunbrig®) for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- BV-CHP (Brentuximab Vedotin (Adcetris®) + Cyclophosphamide + Doxorubicin + Prednisone) for Lymphoma, T-Cell
- C10403 Consolidation for Acute Lymphoid Leukemia (ALL)
- C10403 Delayed Intensification for Acute Lymphoid Leukemia (ALL)
- C10403 Induction for Acute Lymphoid Leukemia (ALL)
- C10403 Interim Maintenance for Acute Lymphoid Leukemia (ALL)
- C10403 Maintenance for Acute Lymphoid Leukemia (ALL)
- Cabazitaxel (Jevtana®) + Prednisone for Prostate Cancer
- Cabozantinib (Cabometyx®) for Liver Cancer
- Cabozantinib (Cabometyx®) for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- Cabozantinib (Cometriq®) for Thyroid Cancer
- Capecitabine (Xeloda®) for Breast Cancer - metastatic
- Capecitabine (Xeloda®) for Colon Cancer
- Capecitabine (Xeloda®) for Bile Duct Cancer
- Capecitabine (Xeloda®) for Breast Cancer - early stage
- Capecitabine (Xeloda®) + Oxaliplatin for Colon Cancer
- Capecitabine (Xeloda®) + Radiation for Rectal Cancer
- Capivasertib (Truqap®) + Fulvestrant (Faslodex®) for Breast Cancer - metastatic
- Capmatinib (Tabrecta®) for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- Carboplatin + Abraxane® (Paclitaxel protein-bound particles); for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- Carboplatin + Docetaxel (Carboplatin + Taxotere®) for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- Carboplatin + Docetaxel (Taxotere®) for Ovarian Cancer
- Carboplatin + Etoposide for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- Carboplatin + Etoposide (Carbo/Etop) for Lung Cancer, Small Cell Lung Cancer (SCLC)
- Carboplatin + Etoposide + Atezolizumab (Tecentriq®) for Lung Cancer, Small Cell Lung Cancer (SCLC)
- Carboplatin + Fluorouracil + Cetuximab (Erbitux®) for Head and Neck Cancer
- Carboplatin + Fluorouracil + Radiation for Head and Neck Cancer
- Carboplatin + Gemcitabine (Gemzar®) for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- Carboplatin + Paclitaxel (Carbo/Taxol®) for Ovarian Cancer
- Carboplatin + Paclitaxel (Carbo/Taxol®) for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- Carboplatin + Paclitaxel (Carbo/Taxol®) for Uterine/Endometrial Cancer
- Carboplatin + Paclitaxel (Carbo/Taxol®) for Breast Cancer - metastatic
- Carboplatin + Paclitaxel + Bevacizumab for Ovarian Cancer
- Carboplatin + Paclitaxel + Pembrolizumab (Keytruda®) followed by Cyclophosphamide + Doxorubicin + Pembrolizumab (Keytruda®) for Breast Cancer - early stage
- Carboplatin + Paclitaxel + Pembrolizumab (Keytruda®) for Uterine/Endometrial Cancer
- Carboplatin + Paclitaxel + Radiation for Esophageal Cancer
- Carboplatin + Paclitaxel + Radiation for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- Carboplatin + Paclitaxel + Radiation for Head and Neck Cancer
- Carboplatin + Pemetrexed (Alimta®) (Carbo/Pem) for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- Carfilzomib (Kyprolis®) for Multiple Myeloma (MM)
- Carmustine (BiCNU®) for Brain Cancer
- Carmustine (BiCNU®) + Bevacizumab for Brain Cancer
- Cemiplimab (Libtayo®) for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- Ceritinib (Zykadia®) for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- Cetuximab (Erbitux®) for Head and Neck Cancer
- CHOP (Cyclophosphamide + Doxorubicin + Vincristine + Prednisone) for Lymphoma, T-Cell
- Cisplatin (Platinol®) + Irinotecan (Camptosar®) for Lung Cancer, Small Cell Lung Cancer (SCLC)
- Cisplatin + Docetaxel for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- Cisplatin + Etoposide for Lung Cancer, Small Cell Lung Cancer (SCLC)
- Cisplatin + Etoposide for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- Cisplatin + Fluorouracil (5-FU) + Cetuximab (Erbitux®) for Head and Neck Cancer
- Cisplatin + Fluorouracil + Trastuzumab for Esophageal Cancer
- Cisplatin + Gemcitabine for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- Cisplatin + Gemcitabine for Bile Duct Cancer
- Cisplatin + Gemcitabine (Gemzar®) for Pancreatic Cancer
- Cisplatin + Gemcitabine + Durvalumab (Imfinzi®) for Bile Duct Cancer
- Cisplatin + Gemcitabine + Durvalumab (Imfinzi®) for Bladder Cancer
- Cisplatin + Gemcitabine + Pembrolizumab (Keytruda®) for Bile Duct Cancer
- Cisplatin + Paclitaxel (Taxol®) for Cervical Cancer
- Cisplatin + Paclitaxel (Taxol®) + Bevacizumab for Cervical Cancer
- Cisplatin + Pemetrexed (Alimta®) for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- Cisplatin + Radiation + Pembrolizumab (Keytruda®) for Cervical Cancer
- Cisplatin + Radiation followed by Carboplatin + Paclitaxel for Uterine/Endometrial Cancer
- Cisplatin + Vinblastine + Radiation for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- Cisplatin + Vinorelbine (Navelbine®) for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- CLAG-M (Cladribine + Cytarabine + G-CSF + Mitoxantrone) for Acute Myeloid Leukemia (AML)
- CRD (Carfilzomib + Revlimid® + Dexamethasone) for Multiple Myeloma (MM)
- Crizotinib (Xalkori®) for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- CyBorD (Cyclophosphamide + Bortezomib + Dexamethasone) for Multiple Myeloma (MM)
- DA-EPOCH-R (Dose Adjusted - Etoposide + Prednisone + Vincristine + Cyclophosphamide + Doxorubicin + Rituximab) for Lymphoma, B-cell
- Dabrafenib (Tafinlar®) + Trametinib (Mekinist®) for Melanoma
- Dabrafenib (Tafinlar®) + Trametinib (Mekinist®) for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- Daratumumab (Darzalex®) for Multiple Myeloma (MM)
- Daratumumab and Hyaluronidase (Darzalex Faspro®) for Multiple Myeloma (MM)
- Dasatinib (Sprycel®) for Chronic Myeloid Leukemia (CML)
- Dasatinib (Sprycel®) for Acute Lymphoid Leukemia (ALL)
- Daunorubicin and cytarabine liposome (Vyxeos®) for Acute Myeloid Leukemia (AML)
- Decitabine (Dacogen®) for Myelodysplastic Syndromes (MDS)
- Decitabine (Dacogen®) for Acute Myeloid Leukemia (AML)
- Decitabine and Cedazuridine (Inqovi®) for Myelodysplastic Syndromes (MDS)
- Dexamethasone (Decadron®) for Immune Thrombocytopenic Purpura (ITP)
- Dexamethasone (Decadron®) for Nausea and Vomiting
- Diphenoxylate and atropine (Lomotil®) for Diarrhea
- DKd (Daratumumab (Darzalex®) + Carfilzomib (Kyprolis®) + Dexamethasone) for Multiple Myeloma (MM)
- Docetaxel (Taxotere®) + Ramucirumab (Cyramza®) for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- Docetaxel (Taxotere®) + Prednisone for Prostate Cancer
- Dose-Dense AC (DD-AC, Doxorubicin + Cyclophosphamide) + TH (Taxol® + Herceptin®) for Breast Cancer - early stage
- Dose-Dense AC (DD-AC, Doxorubicin + Cyclophosphamide) for Breast Cancer - early stage
- Dose-Dense AC (DD-AC, Doxorubicin + Cyclophosphamide) + Weekly Taxol® for Breast Cancer - early stage
- Dose-Dense AC (DD-AC, Doxorubicin + Cyclophosphamide) + Dose-Dense Taxol® for Breast Cancer - early stage
- Dose-Dense MVAC (DD-Methotrexate + Vinblastine + Adriamycin + Cisplatin) for Bladder Cancer
- Dostarlimab (Jemperli®) for Colon Cancer
- DPd (Daratumumab + Pomalidomide + Dexamethasone) for Multiple Myeloma (MM)
- DRd (Daratumumab + Revlimid® + dexamethasone) for Multiple Myeloma (MM)
- DRVd (Daratumumab + Revlimid® + Velcade® + dexamethasone) for Multiple Myeloma (MM)
- Durvalumab (Imfinzi®) for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- Duvelisib (Copiktra®) for Chronic Lymphocytic Leukemia (CLL)
- DVd (Daratumumab + Velcade® (bortezomib) + dexamethasone) for Multiple Myeloma (MM)
- Elacestrant (Orserdu®) for Breast Cancer - metastatic
- Eltrombopag (Promacta®) for Immune Thrombocytopenic Purpura (ITP)
- Enasidenib (IDHIFA®) for Acute Myeloid Leukemia (AML)
- Encorafenib (Braftovi®) + Binimetinib (Mektovi®) for Melanoma
- Encorafenib (Braftovi®) + Cetuximab (Erbitux®) for Colon Cancer
- Enfortumab Vedotin (Padcev®) for Bladder Cancer
- Enfortumab Vedotin (Padcev®) + Pembrolizumab (Keytruda®) for Bladder Cancer
- Enoxaparin (Lovenox®) for Blood Clots
- Enzalutamide (Xtandi®) for Prostate Cancer
- ERd (Elotuzumab (Empliciti®) + Revlimid® + dexamethasone) for Multiple Myeloma (MM)
- Eribulin (Halaven®) for Breast Cancer - metastatic
- Erlotinib (Tarceva®) for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- Everolimus (Afinitor®) for Renal Cell Carcinoma - Kidney Cancer
- Everolimus (Afinitor®) + Exemestane for Breast Cancer - metastatic
- fam-trastuzumab deruxtecan-nxki (Enhertu®) for Breast Cancer - metastatic
- FCR (Fludarabine + Cyclophosphamide + Rituximab) for Chronic Lymphocytic Leukemia (CLL)
- Fedratinib (Inrebic®) for Myelofibrosis
- Fentanyl (Duragesic®) for Pain
- Filgrastim (Neupogen®, Zarxio®, Nivestym®, Releuko®) for Neutropenic Fever
- FLAG-IDA (Fludarabine + Ara-C + G-CSF + Idarubicin) for Acute Myeloid Leukemia (AML)
- FLAG-IDA (Fludarabine + Ara-C + G-CSF + Idarubicin) for Acute Lymphoid Leukemia (ALL)
- FLOT (Fluorouracil + Leucovorin + Oxaliplatin + Docetaxel) for Stomach Cancer
- FLOT (Fluorouracil + Leucovorin + Oxaliplatin + Docetaxel) for Esophageal Cancer
- Fluorouracil (5-FU) + Radiation for Rectal Cancer
- FOLFIRI (Folinic acid + Fluorouracil + Irinotecan) for Colon Cancer
- FOLFIRI (Folinic acid + Fluorouracil + Irinotecan) for Bile Duct Cancer
- FOLFIRI + Bevacizumab for Colon Cancer
- FOLFIRI + Cetuximab (Erbitux®) for Colon Cancer
- FOLFIRI + Panitumumab (Vectibix®) for Colon Cancer
- FOLFIRINOX (Fluorouracil + Leucovorin + Irinotecan + Oxaliplatin) for Pancreatic Cancer
- FOLFOX (Folinic acid + Fluorouracil + Oxaliplatin) for Colon Cancer
- FOLFOX (Folinic acid + Fluorouracil + Oxaliplatin) for Bile Duct Cancer
- FOLFOX + Bevacizumab for Colon Cancer
- FOLFOX + Cetuximab (Erbitux®) for Colon Cancer
- FOLFOX + Panitumumab (Vectibix®) for Colon Cancer
- Fosaprepitant (Emend®) for Nausea and Vomiting
- Fostamatinib (Tavalisse®) for Immune Thrombocytopenic Purpura (ITP)
- Fruquintinib (Fruzaqla®) for Colon Cancer
- Fulvestrant (Faslodex®) for Breast Cancer - metastatic
- Gefitinib (Iressa®) for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- Gemcitabine (Gemzar®) for Pancreatic Cancer
- Gemcitabine (Gemzar®) + Cisplatin for Bladder Cancer
- Gemcitabine (Gemzar®) + Docetaxel (Taxotere®) for Sarcoma
- Gemcitabine + Abraxane® for Pancreatic Cancer
- Gemcitabine + Abraxane® for Bile Duct Cancer
- Gemcitabine + Capecitabine (Xeloda®) for Pancreatic Cancer
- Gilteritinib (Xospata®) for Acute Myeloid Leukemia (AML)
- HiDAC (High Dose Ara-C) for Acute Myeloid Leukemia (AML)
- HiDAC (High Dose Ara-C) + Midostaurin (Rydapt®) for Acute Myeloid Leukemia (AML)
- High-Dose Cisplatin + Radiation for Head and Neck Cancer
- Hydroxyurea (Hydrea®, Droxia®) for Polycythemia Vera
- Hydroxyurea (Hydrea®, Droxia®) for Essential Thrombocythemia
- HyperCVAD (Part A) for Acute Lymphoid Leukemia (ALL)
- HyperCVAD (Part B) for Acute Lymphoid Leukemia (ALL)
- IBR (Ibrutinib + Bendamustine + Rituximab) for Chronic Lymphocytic Leukemia (CLL)
- Ibrutinib (Imbruvica®) for Chronic Lymphocytic Leukemia (CLL)
- Idelalisib (Zydelig®) + Rituximab for Chronic Lymphocytic Leukemia (CLL)
- IE (Ifosfamide + Etoposide) for Sarcoma
- Imatinib (Gleevec®) for Chronic Myeloid Leukemia (CML)
- Imatinib (Gleevec®) for Gastrointestinal Stromal Tumor (GIST)
- Immune Globulin (IVIG, IV IgG) for Immune Thrombocytopenic Purpura (ITP)
- Inavolisib (Itovebi®) + Palbociclib (Ibrance®) + Fulvestrant (Faslodex®) for Breast Cancer - metastatic
- Inotuzumab Ozogamicin (Besponsa®) for Acute Lymphoid Leukemia (ALL)
- Intraperitoneal (IP) Cisplatin + IP Paclitaxel + Intravenous (IV) Paclitaxel for Ovarian Cancer
- IRd (Ixazomib + Revlimid® (lenalidomide) + dexamethasone) for Multiple Myeloma (MM)
- Isa-Kd (Isatuximab (Sarclisa®) + Carfilzomib (Kyprolis®) + dexamethasone) for Multiple Myeloma (MM)
- Isa-Pd (Isatuximab + Pomalidomide + Dexamethasone) for Multiple Myeloma (MM)
- Ivosidenib (Tibsovo®) for Acute Myeloid Leukemia (AML)
- Ivosidenib (Tibsovo®) for Brain Cancer
- Ivosidenib (Tibsovo®) + Azacitidine (Vidaza®) for Acute Myeloid Leukemia (AML)
- Lactulose for Constipation
- Lapatinib (Tykerb®) + Capecitabine (Xeloda®) for Breast Cancer - metastatic
- Lenalidomide (Revlimid®) for Myelodysplastic Syndromes (MDS)
- Lenvatinib (Lenvima®) for Liver Cancer
- Lenvatinib (Lenvima®) + Pembrolizumab (Keytruda®) for Uterine/Endometrial Cancer
- Lenvatinib (Lenvima®) + Pembrolizumab (Keytruda®) for Renal Cell Carcinoma - Kidney Cancer
- Letrozole (Femara®) for Breast Cancer - early stage
- Letrozole (Femara®) for Breast Cancer - metastatic
- Leuprolide acetate (Lupron Depot®, Eligard®) for Prostate Cancer
- Liposomal Doxorubicin (Doxil®) for Sarcoma
- Liposomal Doxorubicin (Doxil®) for Ovarian Cancer
- Liposomal Doxorubicin (Doxil®) + Bevacizumab (Avastin®, Alymsys®, Mvasi®, Zirabev®) for Ovarian Cancer
- Liposomal Doxorubicin (Doxil®) + Carboplatin for Ovarian Cancer
- Lomustine (CCNU, Gleostine®) for Brain Cancer
- Lomustine (Gleostine®) + Bevacizumab for Brain Cancer
- Loncastuximab Tesirine (Zynlonta®) for Lymphoma, B-cell
- Loperamide (Imodium®) for Diarrhea
- Lorazepam (Ativan®) for Nausea and Vomiting
- Low-dose Cytarabine (LDAC) for Acute Myeloid Leukemia (AML)
- Lurbinectedin (Zepzelca®) for Lung Cancer, Small Cell Lung Cancer (SCLC)
- Luspatercept (Reblozyl®) for Myelodysplastic Syndromes (MDS)
- Magnesium Citrate for Constipation
- MAP (Methotrexate + Doxorubicin + Cisplatin) for Sarcoma
- Margetuximab (Margenza®) + Capecitabine (Xeloda®) for Breast Cancer - metastatic
- Maxi-CHOP (also known as Nordic Regimen) for Lymphoma, Mantle Cell
- Melphalan (Evomela®, Alkeran®) for Autologous Stem Cell Transplant (autoSCT)
- Metoclopramide (Reglan®) for Nausea and Vomiting
- Midostaurin (Rydapt®) for Advanced Systemic Mastocytosis
- Mini-Hyper-CVD (Part A) + Inotuzumab Ozogamicin (Besponsa®) for Acute Lymphoid Leukemia (ALL)
- Mini-Hyper-CVD (Part B) + Inotuzumab Ozogamicin (Besponsa®) for Acute Lymphoid Leukemia (ALL)
- Mirvetuximab Soravtansine (Elahere®) for Ovarian Cancer
- Mitomycin + Capecitabine (Xeloda®) + Radiation for Anal Cancer
- Modified FOLFIRINOX (Fluorouracil + Leucovorin + Irinotecan + Oxaliplatin) for Pancreatic Cancer
- Morphine (MSIR, MS Contin®, Kadian®, Arymo® ER, MorphaBond ER®) for Pain
- Nelarabine (Arranon®) for Acute Lymphoid Leukemia (ALL)
- Neratinib (Nerlynx®) for Breast Cancer - early stage
- Nilotinib (Tasigna®) for Chronic Myeloid Leukemia (CML)
- Niraparib (Zejula®) for Ovarian Cancer
- Nivolumab (Opdivo®) for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- Nivolumab (Opdivo®) for Melanoma
- Nivolumab (Opdivo®) for Head and Neck Cancer
- Nivolumab (Opdivo®) for Bladder Cancer
- Nivolumab (Opdivo®) + Ipilimumab (Yervoy®) for Melanoma
- Nivolumab (Opdivo®) for Hodgkin's Lymphoma (HL)
- Nivolumab (Opdivo®) + AVD (Doxorubicin + Vinblastine + Dacarbazine) for Hodgkin's Lymphoma (HL)
- Nivolumab (Opdivo®) + Ipilimumab (Yervoy®) for Colon Cancer
- Nivolumab (Opdivo®) + Ipilimumab (Yervoy®) for Renal Cell Carcinoma - Kidney Cancer
- Nivolumab (Opdivo®) + Ipilimumab (Yervoy®) for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- Nivolumab (Opdivo®) + Ipilimumab (Yervoy®) for Liver Cancer
- Nivolumab + Relatlimab (Opdualag®) for Melanoma
- Olaparib (Lynparza®) for Ovarian Cancer
- Olaparib (Lynparza®) for Breast Cancer - metastatic
- Olaparib (Lynparza®) for Pancreatic Cancer
- Olaparib (Lynparza®) for Breast Cancer - early stage
- Olaparib (Lynparza®) for Prostate Cancer
- Olaparib (Lynparza®) + Abiraterone (Zytiga®) + Prednisone for Prostate Cancer
- Olaparib (Lynparza®) + Bevacizumab for Ovarian Cancer
- Olutasidenib (Rezlidhia®) for Acute Myeloid Leukemia (AML)
- Omacetaxine (Synribo®) for Chronic Myeloid Leukemia (CML)
- Ondansetron (Zofran®, Zofran ODT®) for Nausea and Vomiting
- Osimertinib (Tagrisso®) for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- Osimertinib (Tagrisso®) + Carboplatin + Pemetrexed for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- Osimertinib (Tagrisso®) + Cisplatin + Pemetrexed for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- Oxycodone (Roxicodone®, Percocet®, OxyContin®, Oxaydo®, Xtampza®) for Pain
- Paclitaxel (Taxol®) for Breast Cancer - early stage
- Paclitaxel (Taxol®) + Trastuzumab + Pertuzumab (Perjeta®) for Breast Cancer - early stage
- Paclitaxel + Trastuzumab for Breast Cancer - early stage
- Paclitaxel + Trastuzumab + Pertuzumab for Breast Cancer - metastatic
- Pacritinib (Vonjo®) for Myelofibrosis
- Palbociclib (Ibrance®) + Fulvestrant (Faslodex®) for Breast Cancer - metastatic
- Palbociclib (Ibrance®) + Letrozole (Femara®) for Breast Cancer - metastatic
- Palbociclib (Ibrance®) + Anastrozole (Arimidex®) for Breast Cancer - metastatic
- Palonosetron (Aloxi®) for Nausea and Vomiting
- Pazopanib (Votrient®) for Renal Cell Carcinoma - Kidney Cancer
- PCd (Pomalidomide + Cyclophosphamide + Dexamethasone) for Multiple Myeloma (MM)
- PCV (Procarbazine + Lomustine + Vincristine) for Brain Cancer
- Pegfilgrastim (Neulasta®, Neulasta OnPro®, Udenyca®, Udenyca Onbody®, Fulphila®, Ziextenzo®, Nyvepria®, Fylnetra®, Stimufend®) for Neutropenic Fever
- Peginterferon alfa-2a (Pegasys®) for Polycythemia Vera
- Pembrolizumab (Keytruda®) for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- Pembrolizumab (Keytruda®) for Melanoma
- Pembrolizumab (Keytruda®) for Bladder Cancer
- Pembrolizumab (Keytruda®) for Head and Neck Cancer
- Pembrolizumab (Keytruda®) for Renal Cell Carcinoma - Kidney Cancer
- Pembrolizumab (Keytruda®) + Abraxane® (Paclitaxel protein-bound particles) for Breast Cancer - metastatic
- Pembrolizumab (Keytruda®) + Carboplatin + Abraxane® (Paclitaxel protein-bound particles) for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- Pembrolizumab (Keytruda®) + Carboplatin + Fluorouracil for Head and Neck Cancer
- Pembrolizumab (Keytruda®) + Carboplatin + Gemcitabine for Breast Cancer - metastatic
- Pembrolizumab (Keytruda®) + Carboplatin + Paclitaxel for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- Pembrolizumab (Keytruda®) + Carboplatin + Pemetrexed (Alimta®) for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- Pembrolizumab (Keytruda®) + Cisplatin + Fluorouracil for Head and Neck Cancer
- Pirtobrutinib (Jaypirca®) for Chronic Lymphocytic Leukemia (CLL)
- Pirtobrutinib (Jaypirca®) for Lymphoma, Mantle Cell
- Pola-R-CHP (Polatuzumab Vedotin (Polivy®) + Rituximab + Cyclophosphamide + Doxorubicin + Prednisone) for Lymphoma, B-cell
- Polatuzumab Vedotin (Polivy®) + Bendamustine + Rituximab for Lymphoma, B-cell
- Polatuzumab Vedotin (Polivy®) + Rituximab for Lymphoma, B-cell
- Polyethylene Glycol (MiraLAX®) for Constipation
- Pomalidomide (Pomalyst®) for Multiple Myeloma (MM)
- POMP (6-Mercaptopurine + Vincristine + Methotrexate + Prednisone) for Acute Lymphoid Leukemia (ALL)
- Ponatinib (Iclusig®) for Chronic Myeloid Leukemia (CML)
- Ponatinib (Iclusig®) for Acute Lymphoid Leukemia (ALL)
- Pralsetinib (Gavreto®) for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- Prednisone for Immune Thrombocytopenic Purpura (ITP)
- Prochlorperazine (Compazine®) for Nausea and Vomiting
- Promethazine (Phenergan®) for Nausea and Vomiting
- PVd (Pomalidomide (Pomalyst®) + Bortezomib (Velcade®) + dexamethasone) for Multiple Myeloma (MM)
- R-CHOP (Rituximab + Cyclophosphamide + Doxorubicin + Vincristine + Prednisone) for Lymphoma, B-cell
- R-CHOP/R-DHAP (Rituximab + Cyclophosphamide + Doxorubicin + Vincristine + Prednisone + Dexamethasone + Cytarabine + Cisplatin) for Lymphoma, Mantle Cell
- R-CVP (Rituximab + Cyclophosphamide + Vincristine + Prednisone) for Lymphoma, B-cell
- R-DHAP (Rituximab + Dexamethasone + Cytarabine + Cisplatin) for Lymphoma, Mantle Cell
- R-GemOx (Rituximab + Gemcitabine + Oxaliplatin) for Lymphoma, B-cell
- Ramucirumab (Cyramza®) for Stomach Cancer
- Ramucirumab (Cyramza®) for Liver Cancer
- Rd (Revlimid® + Dexamethasone) for Multiple Myeloma (MM)
- Regorafenib (Stivarga®) for Colon Cancer
- Regorafenib (Stivarga®) for Liver Cancer
- Revumenib (Revuforj®) for Acute Myeloid Leukemia (AML)
- Revumenib (Revuforj®) for Acute Lymphoid Leukemia (ALL)
- Ribociclib (Kisqali®) + Fulvestrant (Faslodex®) for Breast Cancer - metastatic
- Ribociclib (Kisqali®) + Letrozole (Femara®) for Breast Cancer - metastatic
- Ribociclib (Kisqali®) + Letrozole (Femara®) for Breast Cancer - early stage
- Ribociclib (Kisqali®) + Anastrozole (Arimidex®) for Breast Cancer - metastatic
- Ribociclib (Kisqali®) + Anastrozole (Arimidex®) for Breast Cancer - early stage
- RICE (Rituximab + Ifosfamide + Carboplatin + Etoposide) for Lymphoma, B-cell
- Rituximab (Rituxan®, Truxima®, Ruxience® Riabni®) for Immune Thrombocytopenic Purpura (ITP)
- Rituximab (Rituxan®, Truxima®, Ruxience®, Riabni®) for Chronic Lymphocytic Leukemia (CLL)
- Rituximab + High Dose Methotrexate for Lymphoma, Primary CNS (PCNSL)
- Rituximab + Hyaluronidase (Rituxan Hycela®) for Lymphoma, B-cell
- Rituximab + Lenalidomide (Revlimid®) for Lymphoma, Mantle Cell
- Rituximab + Lenalidomide (Revlimid®) for Lymphoma, B-cell
- Rivaroxaban (Xarelto®) for Blood Clots
- Rolapitant (Varubi®) for Nausea and Vomiting
- Romidepsin (Istodax®) for Lymphoma, T-Cell
- Romiplostim (Nplate®) for Immune Thrombocytopenic Purpura (ITP)
- Rucaparib (Rubraca®) for Ovarian Cancer
- Ruxolitinib (Jakafi®) for Myelofibrosis
- Ruxolitinib (Jakafi®) for Polycythemia Vera
- RVd (Revlimid® + Velcade® + dexamethasone) for Multiple Myeloma (MM)
- Sacituzumab Govitecan (Trodelvy®) for Breast Cancer - metastatic
- Senna + Docusate (Senokot-S®, Senna-S®) for Constipation
- Sipuleucel-t (Provenge®) for Prostate Cancer
- Sorafenib (Nexavar®) for Renal Cell Carcinoma - Kidney Cancer
- Sorafenib (Nexavar®) for Liver Cancer
- Sotorasib (Lumakras®) for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- Sunitinib (Sutent®) for Renal Cell Carcinoma - Kidney Cancer
- Talazoparib (Talzenna®) for Breast Cancer - metastatic
- Tamoxifen for Breast Cancer - early stage
- Tamoxifen (Nolvadex®) for Breast Cancer - metastatic
- Tarlatamab (Imdelltra®) for Lung Cancer, Small Cell Lung Cancer (SCLC)
- TC (Docetaxel + Cyclophosphamide) for Breast Cancer - early stage
- TCH (Taxotere® + Carboplatin + Herceptin®) for Breast Cancer - early stage
- TCHP (Taxotere® + Carboplatin + Herceptin® + Perjeta®) for Breast Cancer - early stage
- Teclistamab (Tecvayli®) for Multiple Myeloma (MM)
- Temozolomide (Temodar®) + Radiation for Brain Cancer
- Temsirolimus (Torisel®) for Renal Cell Carcinoma - Kidney Cancer
- Tepotinib (Tepmetko®) for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- THP (Taxotere® + Herceptin® + Perjeta®) for Breast Cancer - metastatic
- Tisagenlecleucel (Kymriah®) CAR T-Cells for Acute Lymphoid Leukemia (ALL)
- Tisotumab Vedotin (Tivdak®) for Cervical Cancer
- Topotecan (Hycamtin®) for Lung Cancer, Small Cell Lung Cancer (SCLC)
- Topotecan + Paclitaxel + Bevacizumab for Cervical Cancer
- TPF (Docetaxel + Cisplatin + Fluorouracil) for Head and Neck Cancer
- Trabectedin (Yondelis®) for Sarcoma
- Tremelimumab (Imjudo®) + Durvalumab (Imfinzi®) for Liver Cancer
- Tremelimumab (Imjudo®) + Durvalumab (Imfinzi®) + Carboplatin + Abraxane® for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- Tremelimumab (Imjudo®) + Durvalumab (Imfinzi®) + Carboplatin + Pemetrexed for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- Tremelimumab (Imjudo®) + Durvalumab (Imfinzi®) + Cisplatin + Pemetrexed for Lung Cancer, Non-Small Cell Lung Cancer (NSCLC)
- Trifluridine and Tipiracil (Lonsurf®) for Colon Cancer
- Tucatinib (Tukysa®) + Trastuzumab + Capecitabine for Breast Cancer - metastatic
- VAdriaC (Vincristine + Cyclophosphamide + Doxorubicin) + IE (Ifosfamide + Etoposide) for Sarcoma
- Vd (Bortezomib (Velcade®) + Dexamethasone) for Multiple Myeloma (MM)
- Vemurafenib (Zelboraf®) + Cobimetinib (Cotellic®) for Melanoma
- Venetoclax (Venclexta®) + Azacitidine (Vidaza®) for Acute Myeloid Leukemia (AML)
- Venetoclax (Venclexta®) + Decitabine (Dacogen®) for Acute Myeloid Leukemia (AML)
- Venetoclax (Venclexta) for Chronic Lymphocytic Leukemia (CLL)
- Venetoclax (Venclexta®) + Obinutuzumab (Gazyva®) for Chronic Lymphocytic Leukemia (CLL)
- VIP (Etoposide + Ifosfamide + Cisplatin) for Testicular Cancer
- Vorasidenib (Voranigo®) for Brain Cancer
- VTd (Velcade® + Thalidomide + dexamethasone) for Multiple Myeloma (MM)
- Weekly Cisplatin + Radiation for Head and Neck Cancer
- XVd (Selinexor (Xpovio®) + Bortezomib (Velcade®) + Dexamethasone) for Multiple Myeloma (MM)
- Zanubrutinib (Brukinsa®) for Lymphoma, Mantle Cell
- Zanubrutinib (Brukinsa®) for Chronic Lymphocytic Leukemia (CLL)
Created: December 15, 2015 Updated: September 9, 2019